IPSC
- Century Therapeutics, Inc.
()
Overview
Company Summary
Century Therapeutics, Inc. is a biotechnology company that specializes in developing novel cell therapies for the treatment of various diseases. The company focuses on developing induced pluripotent stem cell (iPSC) technology to engineer and manufacture off-the-shelf, allogeneic cell therapies.
IPSC technology involves reprogramming adult cells, such as skin or blood cells, into a pluripotent state, allowing them to differentiate into various cell types. Century Therapeutics leverages this technology to create specialized cell therapeutic products for treating hematologic malignancies, solid tumors, and other diseases.
The company's approach involves genetically modifying iPSCs to produce therapeutic cells capable of effectively targeting and destroying cancer cells. These modified cells are then expanded in quantity, quality controlled, and finally administered to patients.
Through its expertise in iPSC technology, Century Therapeutics aims to address some of the limitations associated with current cell therapies, such as the need for personalized treatment and challenges related to supply and cost. By creating a standardized, off-the-shelf cell therapy product, the company aims to improve accessibility and provide more efficient treatment options for patients in need.
In summary, Century Therapeutics is primarily focused on employing iPSC technology to develop and manufacture next-generation cell therapies for the treatment of cancer and other diseases.